NJH-2-056

 Cat No.: BP-400176 4.5  

NJH-2-056 is a DUBTAC rather than a classical degradative PROTAC. Public sources describe it as a deubiquitinase-targeting chimera that links the OTUB1 recruiter EN523 to the CFTR corrector lumacaftor. Its functional design is opposite to conventional PROTAC-mediated degradation: the CFTR-binding portion targets the ΔF508-CFTR chaperone-associated protein complex, while the OTUB1-recruiting element brings a deubiquitinase into proximity to stabilize the target protein. Mechanistically, NJH-2-056 is intended to reduce ubiquitin-dependent turnover and increase CFTR protein stability rather than induce proteasomal destruction. It is useful for studying targeted protein stabilization, deubiquitinase recruitment, CFTR folding and trafficking biology, comparison of DUBTACs with PROTACs, and broader induced-proximity strategies that either remove or rescue disease-relevant proteins.

NJH-2-056

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
PROTAC
Molecular Formula
C41H40F2N6O8
Molecular Weight
782.79
Appearance
Solid

* For research and manufacturing use only. Not for human or clinical use.

SizePriceStockQuantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

  • Comprehensive PROTAC Platform
  • Scientific Expertise & Technical Support
  • Custom Synthesis & Design Service
  • Extensive Product Coverage
  • Cutting-Edge Innovation
  • Fast Delivery & Global Support
  • 24/7 customer service
  • 100% quality assurance
Popular Publications Citing BOC Sciences Products
Solubility
DMSO :100 mg/mL (127.75 mM)
Appearance
Solid
Storage
Store at -20°C
Mechanism

Target: Targets BRD4 and BET bromodomain proteins for experimental targeted protein degradation studies.

Binding Site: Binds the BET acetyl-lysine recognition pocket and cereblon thalidomide-binding domain to support productive ternary complex formation.

Mechanism of Action: NJH-2-056 is designed for use in PROTAC or targeted protein degradation experiments directed toward BRD4 and BET bromodomain proteins. The bifunctional molecule links a target-recognition element to cereblon, promoting proximity between the protein of interest and ubiquitination machinery. Productive ternary-complex formation can drive polyubiquitination and proteasome-dependent target depletion, allowing researchers to compare pharmacological inhibition with protein removal. It is suitable for evaluating degradation potency, kinetics, pathway selectivity, and downstream signaling consequences in engineered or disease-relevant cellular models.

Applications

• PROTAC-Mediated Oncogenic Protein Degradation: NJH-2-056 can be employed in research to selectively degrade oncogenic proteins, thereby elucidating their role in cancer cell proliferation and survival. This approach aids in identifying potential therapeutic targets by observing changes in cell viability upon targeted protein degradation.

• Targeted Degradation in Neurodegenerative Disease Models: Researchers can utilize NJH-2-056 to study the degradation of proteins implicated in neurodegenerative diseases. This application allows for the exploration of protein turnover and aggregation processes, providing insights into disease pathology and potential intervention points.

• PROTAC-Driven Signal Transduction Analysis: NJH-2-056 facilitates the degradation of key signaling proteins, enabling the dissection of complex signal transduction pathways. By observing the effects of protein removal on downstream signaling, researchers can better understand pathway dynamics and identify critical regulatory nodes.

• Investigating Protein Stability and Function: NJH-2-056 serves as a tool for probing protein stability and function by inducing selective degradation. This application helps delineate the functional landscape of target proteins, contributing to a deeper understanding of their role in cellular processes and disease mechanisms.

Stock concentration: *
Desired final volume: *
Desired concentration: *

L

* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2

* Total Molecular Weight:
g/mol
Tip: Chemical formula is case sensitive. C22H30N4O c22h30n40
g/mol
g

Related Product Recommendations

BOC Sciences Support

Please contact us with any specific requirements and we will get back to you as soon as possible.


  • Verification code

We invite you to contact us at or through our contact form above for more information about our services and products.

USA
  • International:
  • US & Canada (Toll free):
  • Email:
  • Fax:
Germany
Inquiry Basket